![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, November 03, 2019 11:31:54 AM
The company will probably be happy to keep this listed over a buck. The individual investor is a wonderful source of revenue, they can milk this approval for quite some time too if they want. For the sake of the people who need the treatment and the investors who made it possible, I hope for real fast track momentum with the SP and the FDA.
All posts are my opinion and not a buy or sell stock recommendation.
I do not work for any financial firm nor am I part of a group of traders.
Recent SESN News
- Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights • PR Newswire (US) • 08/10/2023 11:30:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM